We have examined the differences in ventilatory characteristics between halothane and sevoflurane when used for adult vital capacity induction of anaesthesia. The study was conducted in a randomized, double-blind manner. After 13 patients had been enrolled, the study was curtailed because the blinded observer thought that there was an unacceptably high incidence of adverse events. After the randomization code was revealed, the adverse events were found to be in the halothane group. Although the sample size was small, minute volumes appeared to be maintained in the sevoflurane group. Ventilatory frequencies were similar in the two groups after insertion of the laryngeal mask airway, but tidal volumes were significantly greater in the sevoflurane group (P:0.0013). (Br.
In the course of a recently completed study in which sevoflurane was used for adult gaseous induction, 1 it was noticed that the technique appeared to be associated with tachypnoea 2 of a magnitude not reported previously. Tachypnoea appeared to be responsible for very rapid deepening of anaesthesia and it was postulated that this was associated with an increase in tidal volume. If this is the case, it would appear that sevoflurane used in this way stimulates respiration at these concentrations, although this could be technique-and not agent-specific.
Although vital capacity induction has been attempted with all currently available volatile agents, including irritant agents such as isoflurane, 3 it has been studied most extensively with halothane. [4] [5] [6] This study was undertaken in adults to compare the ventilatory characteristics during high concentration gaseous induction using sevoflurane and halothane.
Patients and methods
Approval for the study was obtained from the local Research Ethics Committee. It was planned to recruit to the study 24 ASA grade I and II patients of both sexes, aged 18-65 yr, undergoing day-case orthopaedic surgery.
Exclusion crtieria were: patients receiving (either acutely or chronically) any drugs that might alter the minimum alveolar concentration of the volatile agent, those with a body mass index 91.5 times normal, those who had received halothane anaesthesia in the previous 3 months, were receiving enzyme-inducing drugs or in whom it was anticipated that large amounts of adrenaline-containing local anaesthetics would be used during operation. The study was randomized and double-blind. All observations were made by a single-blinded investigator (J. E. H.) and all inductions were performed by two anaesthetists familiar with the vital capacity induction technique (T. A. O. and J. I. M. S.). Patients were unpremedicated. The vital capacity technique was explained to patients during the preoperative visit. In the anaesthetic room, patients were allocated to one of two groups. Group 1. Patients' lungs were preoxygenated from a Mapleson C breathing system which was supplied from a separate oxygen source in the anaesthetic room. After preoxygenation, patients were instructed to expire to residual volume. During this time the breathing system was changed to a prefilled Mapleson A breathing system with a 4-litre reservoir bag. Patients then took a vital capacity breath of the gaseous induction mixture which they held for as long as possible. When they could not hold their breath anymore, they were allowed to breathe normally. The induction mixture consisted of 8% sevoflurane (dial concentration) and 66% nitrous oxide in oxygen, with a total fresh gas flow of 6 litre min
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. End-tidal volatile concentrations at the distal end of the system were measured using a Capnomac Ultima monitor (Datex, Helsinki, Finland), and filling of the Mapleson A system was commenced when the monitor indicated a concentration greater than 7.5%. Timing of induction commenced from the start of inhalation after expiration to residual volume.
Group 2. Induction proceeded as in group 1 but 4 % halothane (dial concentration) was used. Filling of the Mapleson A system commenced when the monitor indicated a concentration greater than 3.5%.
In both groups, jaw relaxation was tested every 30 s after loss of the eyelash reflex. When this was achieved, a laryngeal mask airway was inserted. Patients continued to breathe the same concentration of volatile agent for 2 min after insertion of the laryngeal mask airway, after which the anaesthetist was allowed to proceed with an anaesthetic appropriate to the surgical procedure. Any adverse airway events during induction were treated in a manner that was thought appropriate by the anaesthetist.
The vaporizer was draped. The observer wore two face masks to eliminate the smell of the volatile agents and entered the anaesthetic room only when induction was about to commence. The agent indicator and its scale on the agent monitor were covered. The observer recorded the following: (1) time from the start of induction to cessation of finger tapping; (2) time from start of induction to loss of the eyelash reflex; (3) time from start of induction to jaw relaxation and insertion of the laryngeal mask airway; (4) minute volume, ventilatory frequency and tidal volume, 1 and 2 min after insertion of the laryngeal mask airway; and (5) presence or absence of adverse airway events.
Minute volumes and ventilatory frequencies were measured using a vane type spirometer (5410 Volume Monitor, Ohmeda, Louisville, USA) which gave running total averages over the previous six breaths. Tidal volumes were calculated from these values.
Laryngospasm and breath-holding, their duration and any intervention, salivation sufficient to wet a finger, coughing and excitation were noted. Excitation was graded as: no excitation; mild, slight movement of the patient; moderate, more marked movement but insufficient to interfere with induction; and severe patient movement sufficient to disrupt the induction process.
The number of patients required for the study was calculated from observations made during an earlier study using sevoflurane in nitrous oxide and oxygen 1 during which a mean ventilatory frequency of 33 (SD 6.1) bpm was noted after insertion of the laryngeal mask airway. Data for gaseous induction with halothane were less readily available, although a pilot study showed a mean ventilatory frequency of 25 (SD 6) bpm. Thus a difference in ventilatory frequency of 8 bpm could be expected with an SD of 6 bpm, leading to a standardized difference of 1.33. Using Altman's nomogram 7 for a study with a power of 0.90, 24 patients would be needed to give a significant result at the 0.05 level.
Results
After 13 patients had been enrolled, the study was stopped because the blinded observer thought that there was an unacceptably high incidence of adverse events. The randomization code was revealed and the available data examined. Of the 13 patients, six had received halothane and seven sevoflurane inductions. Mean end-expired sevoflurane and halothane concentrations after insertion of laryngeal mask airway were 3.7 (range 3.2-4.5) % and 2.0 (1.7-2.3) %, respectively.
There was a high incidence of adverse events in the halothane group, as shown in table 1. Patient No. 11 rapidly become asystolic shortly after insertion of the laryngeal mask airway. This responded to atropine, adrenaline, intubation and DC shock at 200 J twice and then 360 J. He was found subsequently to be a drug abuser and to have a cardiac conduction defect. He made a full recovery. Patient No. 3 had atrial ectopics during induction of anaesthesia which resolved spontaneously; this patient also had a crowing laryngospasm which was treated by manual ventilation. Ventilation of the lungs did not appear to have an adverse effect on the airway in this patient as laryngospasm resolved within 30 s.
Times to cessation of finger tapping and loss of eyelash reflex were comparable in both groups although times to jaw relaxation and to being settled after insertion of the laryngeal mask airway were significantly more rapid with sevoflurane (table 2) .
Comparable ventilatory frequencies were seen after insertion of the laryngeal mask airway. These were associated with high minute volumes in the sevoflurane group which were maintained over the first 2 min after insertion of the laryngeal mask airway. Large tidal volumes were sustained in this group whereas they had reduced by 2 min in the 
Discussion
Vital capacity induction was described originally using halothane 4 5 and seemed an acceptable technique. These studies were descriptive rather then comparative and indeed, no suitable comparator was available. Ruffle and colleagues' original work 4 used halothane in oxygen alone and Wilton and Thomas developed the technique by adding nitrous oxide to the fresh gas flow so speeding the induction process. In this study, times to loss of eyelash reflex were similar to those achieved by Wilton and Thomas, and we used a similar technique, although the volatile concentration was not turned down after loss of the eyelash reflex.
With the introduction of sevoflurane, direct comparison with halothane was made. 8 Sevoflurane was found to be more acceptable, providing more rapid induction and reduced side effects. We observed similar findings in our study and found that sevoflurane was superior to the extent that it was necessary to curtail the study before completion. Although this was a small study, all patients who received halothane had either an adverse airway event or excessive excitation. The authors were surprised by the incidence of adverse events which was much higher than that in Wilton and Thomas's study. 5 The difference could be explained by deviation from the original description, 5 where halothane concentration was reduced from 4% to 3% after loss of eyelash and then to 2% after another 2 min. In our study we maintained halothane concentration at 4% because we wished to make a high concentration comparison with sevoflurane. Maintaining halothane at this level may have caused the increased side effects. The differing blood-gas solubilities of nitrous oxide and halothane (0.47 and 2.3, respectively) may also have contributed to the adverse events seen during halothane induction, as the less potent, less soluble nitrous oxide would have started to exert its effect first, producing a light plane of anaesthesia before halothane had its effect. The blood-gas solubilities of sevoflurane and nitrous oxide differ to a lesser extent (0.67 and 0.47, respectively). Of patients who experienced adverse events, the patient who had a cardiopulmonary arrest later admitted to illicit use of ephedrine as a performance enhancing drug and was found to have a mild intraventricular conduction defect.
Concentrations of the volatile agents used in this study have been used previously for vital capacity induction: 4% for halothane [4] [5] [6] and 8% for sevoflurane. 9 These were dial settings and the measured concentrations delivered were: greater than 3.5% halothane (4.4 minimum alveolar concentration (MAC) equivalents), and greater than 7.5% sevoflurane (3.8 MAC equivalents). These are not MAC equivalents, but the blood-gas solubility of sevoflurane (0.67) is so much less than that of halothane (2.3) that these were thought to be comparable techniques. A second gas effect from nitrous oxide may have had an influence on both induction times and respiratory characteristics. It would have had a more pronounced influence on the uptake of the more soluble gas halothane, perhaps leading to a dosedependent effect on ventilation, although if this were the case one might then have expected some influence on induction times and this was not seen despite the higher MAC value used. The time to loss of eyelash reflex in the sevoflurane group was nearly 30% shorter than that in the halothane group, although this was not statistically significant. In a small study this is probably a type 2 error. The lack of adverse airway events during sevoflurane induction contributed to the earlier insertion of laryngeal mask airways in this group.
Ventilatory frequencies, and minute and tidal volumes were not noted before insertion of the laryngeal mask airway because of the difficulties in obtaining accurate results when holding a face mask. It was thought that jaw relaxation and laryngeal mask insertion represented a sufficiently definite end-point from which to obtain readings and that depth of anaesthesia would be comparable between the two groups at this stage. Ventilatory characteristics between the two groups appeared to be different. There is sustained hyperventilation associated with the use of high concentrations of sevoflurane. Before insertion of the laryngeal mask airway, ventilatory frequencies increased and in the sevoflurane group this was associated with tidal volumes which were sustained. One would expect a patient whose jaw is relaxed, and in whom it is possible to insert a laryngeal mask airway, to have some degree of respiratory depression. It is possible that jaw relaxation and depression of airway reflexes occur early with sevoflurane, enabling insertion of a laryngeal mask airway during hyperventilation either in the second stage or in the first plane of the third stage of anaesthesia. There may be some central stimulation of respiration before deepening of anaesthesia. Guedel, in his original description of the stages of anaesthesia, 10 noted respiration in the second stage as erratic. Guedel described respiration in the first plane of the third stage as full and rhythmic, the volume being increased; with uneventful first and second stages, the increase in volume may be approximately 25%. With eventful first and second stages, an increased carbon dioxide concentration causes respiratory volume to increase even further. Approximately 1 min after entering the third stage, respiration adjusts to moderate hyperventilation. 10 These stages were described during induction with ether with patients breathing normally and the hyperventilation described was attributed to an increase in arterial carbon dioxide tension. During vital capacity induction, greater accumulation of carbon dioxide might be expected, leading perhaps to a more pronounced effect. Tachypnoea but not hyperventilation did not occur during halothane inductions. During sevoflurane induction, respiration seemed to be regular and associated with hyperventilation. The respiratory pattern could represent either the second stage of anaesthesia in a simpler form, unaffected by the complications of airway irritation and patient movement, or the first plane of the third stage of anaesthesia. Whatever stage was present, the laryngeal mask airways were inserted at an earlier stage of anaesthesia in the sevoflurane group. The end-tidal volatile concentrations at insertion of the laryngeal mask airway would seem to support this, with the mean end-tidal sevoflurane concentration being 3.7% or 1.85 MAC and the mean end-tidal halothane 2.0% or 2.5 MAC.
The use of sevoflurane in a vital capacity induction technique was associated with sustained minute volumes, a phenomena which may be responsible in part for the rapid deepening of anaesthesia in sevoflurane vital capacity induction. Sevoflurane would appear to be superior to halothane for adult vital capacity induction when the initial halothane concentration is maintained throughout the induction period. If adult gaseous induction with halothane is to be used, then perhaps the halothane concentration should be reduced after initial loss of consciousness as in Wilton and Thomas's original description. 5 
